MedTrace Logo

Efficacy and Safety of Azithromycin in Patients With Bronchiolitis Obliterans

NCT05299567 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-03-29

No results posted yet for this study

Summary

Placebo-controlled, double-blind, randomized study. Post-infectious bronchiolitis obliterans (PIBO) patients aged 5 years and older of both sexes were enrolled.

Conditions

  • Bronchiolitis Obliterans

Interventions

DRUG

Azithromycin

Placebo with the same color and size than azithromycin tree days a wek for 6 months

Sponsors & Collaborators

  • Claudio Castanos

    lead OTHER_GOV

Principal Investigators

  • Claudio m Castaños, MD · Hospital de Pediatria "juan P. Garrahan"

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-24
Primary Completion
2011-07-21
Completion
2011-07-21

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05299567 on ClinicalTrials.gov